Quantcast
Home > Quotes > CHFS

CHF Solutions, Inc. Common Stock (CHFS) Quote & Summary Data

CHFS 
$0.7101
*  
0.0776
9.85%
Get CHFS Alerts
*Delayed - data as of Dec. 13, 2018  -  Find a broker to begin trading CHFS now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    CHFS Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
3.15
Today's High / Low
$ 0.80 / $ 0.7002
Share Volume
60,685
50 Day Avg. Daily Volume
173,945
Previous Close
$ 0.7877
52 Week High / Low
$ 4.80 / $ 0.67
Market Cap
5,094,546
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.45

Intraday Chart

Shares Traded

Share Volume:
60,685
50 Day Avg. Daily Volume:
173,945

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -12.62

Trading Range

The current last sale of $0.7101 is 5.99% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.80 $ 4.80
 Low: $ 0.7002 $ 0.67

Company Description (as filed with the SEC)

We are medical device company focused on commercializing the Aquadex FlexFlow┬« system. Our commercial product, the Aquadex FlexFlow system, is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. Company History Prior to July 2016, we were focused on developing the C-Pulse┬« Heart Assist System for treatment of Class III and ambulatory Class IV heart failure. The C-Pulse System utilized the known concept of counterpulsation applied to the aorta. In March 2016, we announced that we were no longer enrolling patients into our two clinical studies for the C-Pulse System and that we planned to pursue a new strategic direction.  ... More ...  


Risk Grade

Where does CHFS fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 0.80
Open Date:
Dec. 13, 2018
Close Price:
$ 0.7111
Close Date:
Dec. 13, 2018

Consensus Recommendation

Analyst Info